Ciprofloxacin v placebo for treatment of Yersinia enterocoliticatriggered reactive arthritis
Authors:
- J A A Hoogkamp-KorstanjeJHJ A A Hoogkamp-Korstanje
- H MoeskerHMH Moesker
- G A W BruynGBG A W Bruyn
- 1 November 2000
- journal article
- clinical trial
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 59 (11) , 914-917
Abstract
Patients with yersinia triggered reactive arthritis were double blind randomly allocated to receive treatment with ciprofloxacin 500 mg twice daily orally or placebo during three months. The diagnosis was made by serology (specific IgA and IgG antibodies to yersinia outer membrane proteins (yops)), positive culture, and/or demonstration of Yersinia enterocolitica antigen in colon biopsy specimens. Patients were evaluated monthly during and after treatment up to 12 months. Of 18 patients enrolled, all could be evaluated for safety, 16 for efficacy. There was a tendency towards faster remission and relief of pain in those receiving ciprofloxacin. Y enterocolitica was eliminated from the gut associated lymphoid tissue in six of seven patients receiving ciprofloxacin compared with none of nine patients receiving placebo. Patients receiving placebo had more and prolonged circulating IgA antibodies against yops than patients treated with ciprofloxacin.Keywords
This publication has 10 references indexed in Scilit:
- No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: A three-month, multicenter, double-blind, randomized, placebo-controlled studyArthritis & Rheumatism, 1999
- Experimental Yersinia-triggered reactive arthritis: effect of a 3-week course of ciprofloxacinRheumatology, 1997
- Persistent Yersinia enterocolitica infection in three rat strainsMicrobial Pathogenesis, 1995
- Arthritogenicity of genetically manipulated Yersinia enterocolitica serotype O8 for Lewis ratsInfection and Immunity, 1995
- Influence of antibiotics on IgA and IgG response and persistence ofYersinia enterocolitica in patients with yersinia-associated spondylarthropathyInfection, 1992
- Immunoblot analysis of IgM, IgG, and IgA responses to plasmid encoded released proteins of Yersinia enterocolitica in patients with or without yersinia triggered reactive arthritis.Annals of the Rheumatic Diseases, 1989
- Yersinia in Intestinal Biopsy Specimens from Patients with Seronegative Spondyloarthropathy: Correlation with Specific Serum IgA AntibodiesThe Journal of Infectious Diseases, 1989
- Association of persisting IgA response with yersinia triggered reactive arthritis: a study on 104 patients.Annals of the Rheumatic Diseases, 1987
- Antibiotics in Yersinia enterocolitica infectionsJournal of Antimicrobial Chemotherapy, 1987
- Incidence of Human Infection with Yersinia enterocolitica Serotypes 03, 08, and 09 and the Use of Indirect Immunofluorescence in DiagnosisThe Journal of Infectious Diseases, 1986